ESC 365 - Empagliflozin improves prognosis and energetic properties through modulating mitochondrial function in failing murine hearts

ESC Premium Access

Empagliflozin improves prognosis and energetic properties through modulating mitochondrial function in failing murine hearts

Session: Novel therapies for heart failure in the early pipeline

Topic: Experimental Heart Failure

Speaker: Doctor A. Shiraki (Saga, JP)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Aya Shiraki

Saga University, Saga (Japan)

0 follower

2 more presentations in this session

Low level transcutaneous vagus nerve stimulation reverses cardiac dysfunction and changes left ventricular gene expression in a rat model of heart failure with preserved ejection fraction

Speaker: Doctor M. Niewiadomska (Oklahoma City, US)

Therapeutic role of Prostaglandin E2 receptor 4 stimulation in inflammatory cardiomyopathy

Speaker: Doctor T. Akira (Yokohama, JP)

Access the full session

Novel therapies for heart failure in the early pipeline

Speakers: Doctor A. Shiraki, Doctor M. Niewiadomska, Doctor T. Akira

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by